Loading...
Addex Therapeutics Ltd
0QNV.L•LSE
Healthcare
Biotechnology
£0.06
£-0.00(-1.35%)
Addex Therapeutics Ltd (0QNV.L) Financial Performance & Income Statement Overview
Review Addex Therapeutics Ltd’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-74.58%
↓ 74.58%
Operating Income Growth
73.20%
↑ 73.20%
Net Income Growth
166.84%
↑ 166.84%
Operating Cash Flow Growth
32.77%
↑ 32.77%
Operating Margin
-1045.30%
↓ 1045.30%
Gross Margin
68.69%
↑ 68.69%
Net Profit Margin
3521.74%
↑ 3521.74%
ROE
83.21%
↑ 83.21%
ROIC
-30.53%
↓ 30.53%
Addex Therapeutics Ltd (0QNV.L) Income Statement & Financial Overview
Review Addex Therapeutics Ltd's (0QNV.L) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $1508.00 | $53837.00 | $115277.00 | $234910.00 |
| Cost of Revenue | $1508.00 | $0.00 | $0.00 | -$90.00 |
| Gross Profit | $0.00 | $53837.00 | $115277.00 | $235000.00 |
| Gross Profit Ratio | $0.00 | $1.00 | $1.00 | $1.000 |
| R&D Expenses | $65349.00 | $77847.00 | $184461.00 | $245125.00 |
| SG&A Expenses | $357982.00 | $337248.00 | $507166.00 | $774939.00 |
| Operating Expenses | $423331.00 | $676036.00 | $1.01M | $1.02M |
| Total Costs & Expenses | -$447134.00 | $676036.00 | $1.01M | $1.02M |
| Interest Income | $0.00 | $102.00 | $1507.00 | $7571.00 |
| Interest Expense | $1486.00 | $586.00 | $864.00 | $611.00 |
| Depreciation & Amortization | $23803.00 | $53575.00 | $112382.00 | $2938.00 |
| EBITDA | -$1.16M | -$1.47M | -$1.34M | -$731633.00 |
| EBITDA Ratio | -$772.24 | -$27.37 | -$11.65 | -$3.11 |
| Operating Income | -$445626.00 | -$622199.00 | -$899316.00 | -$788090.00 |
| Operating Income Ratio | -$295.51 | -$11.56 | -$7.80 | -$3.35 |
| Other Income/Expenses (Net) | -$744205.00 | -$905373.00 | -$557445.00 | $52914.00 |
| Income Before Tax | -$1.19M | -$1.53M | -$1.46M | -$735178.00 |
| Income Before Tax Ratio | -$789.01 | -$28.37 | -$12.64 | -$3.13 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $3.09M |
| Net Income | -$1.21M | -$1.53M | $12.88M | -$3.09M |
| Net Income Ratio | -$799.56 | -$28.42 | $111.72 | -$13.14 |
| EPS | -$0.01 | -$0.02 | $0.13 | -$0.03 |
| Diluted EPS | -$0.01 | -$0.009 | $0.08 | -$0.03 |
| Weighted Avg Shares Outstanding | $98.34M | $98.30M | $98.31M | $97.53M |
| Weighted Avg Shares Outstanding (Diluted) | $98.34M | $98.30M | $167.99M | $97.53M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan